Brainsway (BWAY) Change in Acquisitions & Divestments (2019 - 2026)
Brainsway (BWAY) posted quarterly Change in Acquisitions & Divestments of $3000.0 for Q1 2026, up 100.03% on a QoQ basis from -$10.0 million in Q2 2025.
Brainsway (BWAY) Change in Acquisitions & Divestments (2019 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Change in Acquisitions & Divestments for 7 consecutive years, with $3000.0 the latest figure, recorded in Q1 2026.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$45.0 million (changed N/A YoY) and the FY2023 annual result came in at $32000.0, down 99.92% from the prior year.
- Change in Acquisitions & Divestments improved to $3000.0 in Q1 2026 per BWAY's latest filing, from -$10.0 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for BWAY reached as high as $40.3 million in Q2 2022 and fell as low as -$35.0 million in Q4 2023.
- A 4-year average of -$671714.3 and a median of $3000.0 in 2026 frame the typical range for Change in Acquisitions & Divestments.
- The largest YoY upside for Change in Acquisitions & Divestments was 52242.86% in 2022 against a maximum downside of 155.56% in 2022.
- Year by year, Change in Acquisitions & Divestments stood at $9000.0 in 2022, then slumped by 388988.89% to -$35.0 million in 2023, then soared by 71.43% to -$10.0 million in 2025, then jumped by 100.03% to $3000.0 in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $3000.0, -$10.0 million, and -$35.0 million for Q1 2026, Q2 2025, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.64 Bn | 176.34 Bn | 6.27 Bn |
| 2 | Stryker | 129.04 Bn | 126.16 Bn | 3.81 Bn |
| 3 | Medtronic | 109.04 Bn | 99.82 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.67 Bn | 45.00 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.34 Bn | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.36 Bn | 2.07 Bn |
| 10 | Brainsway | 592.12 Mn | 532.35 Mn | 11.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Jun 30, 2025 | -10.00 Mn |
| Jun 30, 2025 | -10.00 Mn |
| Dec 31, 2023 | -35.00 Mn |
| Dec 31, 2023 | -35.00 Mn |
| Jun 30, 2023 | 32,000.00 |
| Jun 30, 2023 | 32,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 40.30 Mn |
| Jun 30, 2022 | 40.30 Mn |
| Mar 31, 2022 | -50,000.00 |
| Mar 31, 2022 | -50,000.00 |
| Dec 31, 2021 | 23,000.00 |
| Dec 31, 2021 | 23,000.00 |
| Sep 30, 2021 | 302,000.00 |
| Sep 30, 2021 | 302,000.00 |
| Jun 30, 2021 | 77,000.00 |
| Jun 30, 2021 | 77,000.00 |